AUM Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- AUM Biosciences's estimated annual revenue is currently $3.4M per year.
- AUM Biosciences's estimated revenue per employee is $155,000
Employee Data
- AUM Biosciences has 22 Employees.
- AUM Biosciences grew their employee count by 0% last year.
AUM Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, CEO | Reveal Email/Phone |
AUM Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.9M | 63 | -24% | $15M | N/A |
#2 | $20M | 129 | -16% | $150M | N/A |
#3 | $3.7M | 48 | -6% | $53M | N/A |
#4 | $5.4M | 35 | -8% | N/A | N/A |
#5 | $3.6M | 23 | -18% | N/A | N/A |
#6 | $3.4M | 22 | 0% | N/A | N/A |
#7 | $5.4M | 35 | 6% | N/A | N/A |
#8 | $7.1M | 46 | -26% | N/A | N/A |
#9 | $36.1M | 233 | 4% | N/A | N/A |
#10 | $3.1M | 20 | -61% | N/A | N/A |
What Is AUM Biosciences?
AUM is a clinical-stage biopharmaceutical company aiming to democratize R&D with a focus on discovering, acquiring, and developing novel therapeutics in oncology. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class technologies with strong composition of matter patents in all major territories. 1) MNK Inhibition and 2) Multi-Kinase Inhibition (PIM/PI3K/mTOR). AUM utilizes a proprietary partnered AI-augmented platform to systematically discover and develop targeted cancer therapies focused on genetic targets. AUM's most advanced program is Phase II ready in colorectal cancer, and 2 additional pre-clinical programs have clear pathways to orphan drug designation. For 2 years in a row, the company has been awarded the Frost & Sullivan Asia-Pacific Biotech Entrepreneurial Company of the Year Award.
keywords:N/AN/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AUM Biosciences News
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies. AUM has an...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.2M | 22 | N/A | N/A |
#2 | $2.2M | 22 | N/A | N/A |
#3 | $4.4M | 22 | N/A | N/A |
#4 | $2.2M | 22 | 5% | N/A |
#5 | $2.2M | 22 | 10% | N/A |